Overview A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors Status: Completed Trial end date: 2017-02-01 Target enrollment: Participant gender: Summary This is a phase 1 study of TAS-114 in combination with S-1 in patients with advanced solid tumors. Phase: Phase 1 Details Lead Sponsor: Taiho Pharmaceutical Co., Ltd.